Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Oropharyngeal squamous cell carcinoma
ADR ID BADD_A03209
ADR Hierarchy
07      Gastrointestinal disorders
07.21      Malignant and unspecified neoplasms gastrointestinal NEC
07.21.07      Malignant oral cavity neoplasms
07.21.07.005      Oropharyngeal squamous cell carcinoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.19      Respiratory and mediastinal neoplasms malignant and unspecified
16.19.05      Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified
16.19.05.004      Oropharyngeal squamous cell carcinoma
22      Respiratory, thoracic and mediastinal disorders
22.08      Respiratory tract neoplasms
22.08.02      Upper respiratory tract neoplasms
22.08.02.006      Oropharyngeal squamous cell carcinoma
Description Not Available
MedDRA Code 10031112
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Oropharyngeal squamous cell carcinoma | Oropharyngeal squamous cell carcinoma recurrent | Oropharyngeal squamous cell carcinoma stage 0 | Oropharyngeal squamous cell carcinoma stage I | Oropharyngeal squamous cell carcinoma stage II | Oropharyngeal squamous cell carcinoma stage III | Oropharyngeal squamous cell carcinoma stage IV | HPV positive oropharyngeal squamous cell carcinoma | Human papilloma virus positive oropharyngeal squamous cell carcinoma
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01253Lenalidomide0.000241%
BADD_D02344Vemurafenib--
BADD_D02407Upadacitinib0.000241%
BADD_D02464Fingolimod0.000241%
The 1th Page    1    Total 1 Pages